Therefore, (+)-JQ1 potentially competes for and binds to the CLCF1, AEBP1, and OS9 proteins, resulting in the interruption of the pro-oncogenic pathway in PTNE-mut gliomas. This evidence concerns the gene OS9 and central nervous system cancer.